iRhythm Holdings, Inc.
For the period ended Dec 31, 2025. Filed Feb 19, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 19, 2026
IRTC$86.06-3.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
Consolidated Statements of Cash Flows
| Year Ended December 31, | |||
|---|---|---|---|
| 2025 · 2024 · 2023 | |||
| Cash flows from operating activities | |||
| Net loss | $(44,551) | $(113,289) | $(123,406) |
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||
| Depreciation and amortization | 20,742 | 20,715 | 16,348 |
| Stock-based compensation | 88,283 | 75,978 | 77,204 |
| Amortization of premium and accretion of discounts, net | (3,127) | (1,350) | (5,040) |
| Amortization of operating lease right-of-use assets | 5,737 | 5,062 | 5,796 |
| Amortization of debt discount | 3,060 | 2,796 | 15 |
| Change in fair value of strategic investments | (5,711) | (1,902) | — |
| Provision for credit losses and contractual allowances | 99,666 | 73,463 | 69,628 |
| Acquired in-process research and development | 3,036 | 32,371 | — |
| Loss on extinguishment of debt | — | 7,589 | — |
| Impairment charges | 4,458 | 641 | 11,078 |
| Other | 967 | 432 | 322 |
| Changes in operating assets and liabilities: | |||
| Accounts receivable | (95,431) | (91,920) | (81,193) |
| Inventory | (8,512) | (224) | 979 |
| Prepaid expenses and other current assets | (5,380) | 5,305 | (11,036) |
| Other assets | (2,894) | 3,221 | (22,787) |
| Accounts payable and accrued liabilities | 28,044 | (7,408) | 17,325 |
| Deferred revenue | 1,269 | (374) | 255 |
| Operating lease liabilities | (8,793) | (7,716) | (5,589) |
| Net cash provided by (used in) operating activities | 80,863 | 3,390 | (50,101) |
| Cash flows from investing activities | |||
| Purchases of property and equipment | (46,342) | (33,942) | (40,424) |
| Purchases of marketable securities | (466,114) | (118,241) | (164,285) |
| Maturities of marketable securities | 237,700 | 101,200 | 206,500 |
| Purchases of strategic investments | (2,300) | (57,000) | (3,000) |
| Purchase of acquired in-process research and development | — | (15,000) | — |
| Net cash used in investing activities | (277,056) | (122,983) | (1,209) |
| Cash flows from financing activities | |||
| Payment of SVB term loan and termination costs | — | (37,751) | — |
| Proceeds from Braidwell debt | — | 75,000 | — |
| Payments of issuance costs for Braidwell debt | — | (2,100) | — |
| Payment of Braidwell debt and termination costs | — | (78,660) | — |
| Proceeds from issuance of 2029 notes | — | 661,250 | — |
| Payments of issuance costs for 2029 notes | — | (17,424) | — |
| Purchases of capped call transactions | — | (72,407) | — |
| Purchase of treasury stock | — | (25,000) | — |
| Proceeds from issuance of common stock in connection with employee equity incentive plans | 12,607 | 8,473 | 8,820 |
| Net cash provided by financing activities | 12,607 | 511,381 | 8,820 |
| Effect of exchange rate changes | 1 | (6) | (169) |
| Net increase (decrease) in cash and cash equivalents | (183,585) | 391,782 | (42,659) |
| Cash and cash equivalents, beginning of year | 427,955 | 36,173 | 78,832 |
| Cash and cash equivalents, end of year | $244,370 | $427,955 | $36,173 |
| Year Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Reconciliation of cash, cash equivalents and restricted cash | |||
| Cash and cash equivalents | $236,012 | $419,597 | $36,173 |
| Restricted cash | $8,358 | $8,358 | $— |
| Total cash, cash equivalents and restricted cash | $244,370 | $427,955 | $36,173 |
| Supplemental disclosures of cash flow information: | |||
| Interest paid | $9,919 | $6,389 | $2,960 |
| Cash taxes paid | $1,196 | $923 | $1,130 |
| Cash paid for operating lease liabilities | $15,875 | $15,177 | $14,105 |
| Cash received from tenant improvement allowances | $745 | $736 | $1,603 |
| Non-cash investing and financing activities: | |||
| Property and equipment costs included in accounts payable and accrued liabilities | $407 | $275 | $1,888 |
| Right-of-use assets obtained in exchange for operating lease liabilities | $— | $4,009 | $4,403 |
| Capitalized stock-based compensation in property and equipment | $5,261 | $6,779 | $7,383 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.